Announced on April 18, the approval is based on the VISIBLE 2 trial and comes less than 7 months after the approval of SC vedolizumab in ulcerative colitis.

Post-treatment with risankizumab, the cDAPSA score, PGA score, and PASI score substantially decreased among a cohort of patients with psoriatic arthritis.

Prolonged modified fasting, in a multimodal medical approach, may help patients with fibromyalgia improve pain and psychosomatic symptoms.

Cerceo, Peden, and Ziska joined HCPLive to speak on the imminent threat posed by climate change, highlighting the impact especially on individuals with allergic disease.

Nahas reviews key highlights from her session at ACP, emphasizing the importance of reviewing patient history and considering what other factors may be causing headaches.

Branch discusses key takeaways from his session at ACP and guideline recommendations for primary and secondary prevention of cardiovascular disease.

A poll found people were more likely to use alternate health care sites if they were women, aged 50 – 64 over 65 – 80 years, and had a household income of < $60,000.

Thorndike discussed highlights from her ACP 2024 talk titled ‘Annals Beyond the Guidelines: How Would You Treat this Patient with Obesity?’

An extension study showed upadacitinib 15 mg and 30 mg for rheumatoid arthritis continues to be favorable, with many patients achieving remission.

Contrary to previous research, findings point to similar decreases in weight and improvements in glucose homeostasis between time-restricted eating and usual eating pattern groups.

In this segment of his interview, Leff described what he hopes internal medicine physicians viewing his talk walk away realizing about Hospital at Home.

At the ACP Internal Medicine Meeting, Leff described the outcomes and implementation of the ‘Hospital at Home’ program for elderly adults.

Data presented at ACP 2024 shows non-White patients may be particularly subjected to more risk of discrimination in their care when ED boarding extends past 24 hours.

This discussion with Hemming featured the biggest takeaways from his talk titled ‘Depression and Anxiety Treatment by the Internal Medicine Physician.’

Markland discusses the use of anticholinergics, beta 3-agonists, and nonpharmacologic treatments for urge urinary incontinence, based on her session at ACP.

Wilt discusses the different screening methods recommended by ACP and explains how he talks about screening with his patients.

This interview at ACP 2024 featured a discussion with Hemming on the Mental Health Care Model (MHCM) and addressing depression in primary care settings.

This presentation at ACP Internal Medicine 2024 covered key skills Colven believes internists should know for identification of dermatologic conditions.

Berg discusses takeaways from his session at the 2024 ACP Internal Medicine meeting, including considerations for the diagnosis and management of acute coronary syndrome.

A study presented at ACP 2024 shows benefit with preparing to offer pneumococcal vaccination to incoming patients in an ambulatory setting.

This data presented at ACP Internal Medicine 2024 highlights several important findings on older adults, dementia, dual-tasking, and cognitive decline.

Cerceo discusses key topics from her session at the ACP Internal Medicine meeting about health care providers’ role in discussing climate-related health with their patients

In this Q&A, Kathuria explains the current state of smoking cessation programs and how health care providers can help patients combat their tobacco dependence.

During this segment of her interview at the ACP Internal Medicine Meeting, Jay discussed improving obesity care, telehealth utilization for patients, and more.

In this episode, hosts break down the latest type 2 diabetes recommendations from the American College of Physicians and offer their perspective on second-line therapies in T2D.